GlassScriptPhysician profile
Ziad G Labbad
NPI 1467447466
$1,478.38
in general payments reported to CMS, 2019-2025
25 companies · $666 in 2025
The $666 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $76.37 · 2021: $22.87 · 2022: $32.77 · 2023: $173 · 2024: $96.67 · 2025: $666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $256.96 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $249.73 | 2019-2023 | Grafix Pl |
| Organogenesis INC. | $156.27 | 2019-2025 | Affinity, Apligraf |
| Depuy Synthes Sales INC. | $102.47 | 2025 | Na |
| Celgene Corporation | $93.33 | 2019 | |
| Sebela Pharmaceuticals INC. | $69.07 | 2019 | |
| Orthofix Medical, INC. | $60.54 | 2024 | Truelok |
| Dynasplint Systems INC. | $56.31 | 2019 | |
| Averitas Pharma INC. | $53.21 | 2025 | Qutenza |
| Paratek Pharmaceuticals, INC. | $47.67 | 2023-2024 | Nuzyra |
| Amgen INC. | $46.18 | 2020-2025 | |
| Alexion Pharmaceuticals, INC. | $32.91 | 2019-2020 | |
| Solventum Corporation | $30.86 | 2025 | Activ.A.C. |
| Lifenet Health | $24.29 | 2025 | Theragenesis Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $22.95 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polarityte, INC. | $22.14 | 2019 | |
| Btg International INC. | $21.96 | 2025 | Aurlumyn |
| Wright Medical Technology, INC. | $21.68 | 2020 | |
| Tactile Systems Technology INC | $20.28 | 2022 | |
| Arcutis Biotherapeutics, INC. | $18.08 | 2023 | |
| Nevro Corp. | $18.03 | 2023 | Senza |
| Hartmann USA, INC. | $15.06 | 2025 | Zetuvit Plus 10x10 P10 |
| Convatec INC. | $13.39 | 2020 | |
| Bsn Medical INC | $12.52 | 2024 | |
| Biotissue Holdings INC. | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ziad Labbad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.